Evren Oktem
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Evren Oktem has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Abhishek Jain
Department of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, USA
1 shared publication - Alessia Andrea Ricci
Pathology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
1 shared publication - Ankit Kumar
Department of Biomedical Engineering, Texas A&M University 1 , College Station, Texas 77840
1 shared publication Antonia Stammberger
Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany
1 shared publication- Brian Sanders
Department of Physics and Astronomy, Texas A&M University 2 , College Station, Texas 77840
1 shared publication Carmen Ortega-Sabater
CNIO Biobank, Spanish National Cancer Research Centre, Madrid, Spain
1 shared publication
Latest Publications
- 2 November 2026
- Published by AIP Publishing in Applied Physics Letters
- Vol. 129 (18)
Microfluidic Brillouin platform for frequency-resolved mechanics of complex fluids
We introduce an integrated microfluidic platform that combines pressure-flow rheology with depth-resolved Brillouin microspectroscopy to investigate complex fluids in extensive frequency ranges. Apparent viscosity is measured via calibrated pressure-flow in a rectangular polydimethylsiloxane microchannel, while GHz-frequency Brillouin spectroscopy probes longitudinal mechanics under identical steady-flow conditions. Using semi-dilute methylcellulose solutions in a cell-culture medium as a model, we reveal mild shear-thinning behavior, whereas the Brillouin frequency shift and linewidth values remain constant throughout the flow rate range, mainly influenced by polymer concentration. This confirms the decoupling between steady-shear and GHz-frequency acoustic responses observed previously. The platform offers a compact, calibrated approach for frequency-resolved mechanical analysis of flowing soft materials and perfused media.
- 2 November 2026
- Published by AIP Publishing in Applied Physics Letters
- Vol. 129 (18)
Microfluidic Brillouin platform for frequency-resolved mechanics of complex fluids
We introduce an integrated microfluidic platform that combines pressure-flow rheology with depth-resolved Brillouin microspectroscopy to investigate complex fluids in extensive frequency ranges. Apparent viscosity is measured via calibrated pressure-flow in a rectangular polydimethylsiloxane microchannel, while GHz-frequency Brillouin spectroscopy probes longitudinal mechanics under identical steady-flow conditions. Using semi-dilute methylcellulose solutions in a cell-culture medium as a model, we reveal mild shear-thinning behavior, whereas the Brillouin frequency shift and linewidth values remain constant throughout the flow rate range, mainly influenced by polymer concentration. This confirms the decoupling between steady-shear and GHz-frequency acoustic responses observed previously. The platform offers a compact, calibrated approach for frequency-resolved mechanical analysis of flowing soft materials and perfused media.
- Open Access
- 3 July 2026
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 18 (8) , 1-11
Patient-derived resources for decoding and targeting brain metastases ecosystems
Brain metastases (BrM) affect up to 30% of patients with solid tumors, yet durable intracranial control remains rare, and the biological drivers of this poor prognosis are incompletely understood. Patient-derived resources, such as clinical cohorts, biobanks, functional ex vivo models, and multi-omic platforms, are central to closing this gap, but their generation and integration face substantial logistical and technical hurdles. Drawing on the RISEbrain consortium's experience, this Perspective examines BrM-focused cohorts and biobanks, highlighting the underused potential of rapid autopsy programs to capture early metastatic seeding. We discuss patient-derived organotypic cultures and emerging organoid-based "avatar" systems as functional platforms for therapeutic profiling, alongside the complementary strengths of bulk and single-cell/-nucleus transcriptomics. We outline how spatial transcriptomics and proteomics are resolving the architecture of the BrM microenvironment, and assess liquid biopsy approaches, including emerging photonic biosensors, for non-invasive monitoring. Together, these resources form an interdependent toolkit whose coordinated deployment will advance early detection, prevention, and precision treatment of BrM.
- 3 July 2026
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 18 (8) , 1-11
Open AccessPatient-derived resources for decoding and targeting brain metastases ecosystems
Brain metastases (BrM) affect up to 30% of patients with solid tumors, yet durable intracranial control remains rare, and the biological drivers of this poor prognosis are incompletely understood. Patient-derived resources, such as clinical cohorts, biobanks, functional ex vivo models, and multi-omic platforms, are central to closing this gap, but their generation and integration face substantial logistical and technical hurdles. Drawing on the RISEbrain consortium's experience, this Perspective examines BrM-focused cohorts and biobanks, highlighting the underused potential of rapid autopsy programs to capture early metastatic seeding. We discuss patient-derived organotypic cultures and emerging organoid-based "avatar" systems as functional platforms for therapeutic profiling, alongside the complementary strengths of bulk and single-cell/-nucleus transcriptomics. We outline how spatial transcriptomics and proteomics are resolving the architecture of the BrM microenvironment, and assess liquid biopsy approaches, including emerging photonic biosensors, for non-invasive monitoring. Together, these resources form an interdependent toolkit whose coordinated deployment will advance early detection, prevention, and precision treatment of BrM.